A human leptin mutant induces weight gain in normal mice.
Leptin, a fat secreted hormone, regulates ingestive behaviour and energy balance by binding to a specific receptor. Using site-directed mutagenesis, we screened for single amino acid residues in human leptin which are critical for receptor binding and biological activity. Here we report that one of these mutants has in vivo antagonistic properties. An Arg to Gln substitution at position 128 of human leptin does not affect receptor binding but knocks out biological activity. Repeated injection of R128Q in normal C57BL/6J mice results in a progressive increase in body weight. This demonstrates that R128Q is able to interfere with the negative feedback control of endogenous leptin. This mutant could be of therapeutic use for wasting disorders, such as anorexia and cachexia, where weight gain would be beneficial.
Verploegen
S A
SA
Roche Research Gent, Belgium.
Plaetinck
G
G
Devos
R
R
Van der Heyden
J
J
Guisez
Y
Y
D000818:Animals; D002352:Carrier Proteins / Q000037:antagonists & inhibitors*; D006801:Humans; D020738:Leptin; D051379:Mice; D008810:Mice, Inbred C57BL; D008820:Mice, Obese; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D009765:Obesity / Q000139:chemically induced*; D011506:Proteins / Q000235:genetics*; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D012641:Selection, Genetic; D015430:Weight Gain
D002352:Carrier Proteins; C515448:LEPR protein, human; D020738:Leptin; D011506:Proteins; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; C515447:leptin receptor, mouse